학술논문
COVID-19 vaccination rate and willingness of an additional dose among inflammatory bowel disease patients receiving biologic therapy: Fearless and with desire
Document Type
Article
Author
Source
Gastroenterología y Hepatología (ScienceDirect); 20220101, Issue: Preprints
Subject
Language
ISSN
02105705
Abstract
Effective vaccines against the SARS-CoV-2 are already available and offer a promising action to control the COVID-19 pandemic. IBD patients on biological agents accept the vaccine as well as an additional dose if recommended.